Skip to main content
Top
Published in: Journal of Cancer Education 6/2021

01-12-2021

A Critical Appraisal and Targeted Intervention of the Oncology Experience in an Internal Medicine Residency

Authors: Ghulam Rehman Mohyuddin, Anthony Dominick, Travis Black, Marc Hoffman, Heather Male, Kenneth Byrd, Brian McClune, Leigh Eck, Prakash Neupane

Published in: Journal of Cancer Education | Issue 6/2021

Login to get access

Abstract

Most oncology education is provided to residents on an inpatient oncology service, with limited outpatient exposure. There exists considerable need to develop effective education strategies to teach resident physicians basic concepts in oncology. We created a 2-hour small-group interactive workshop, using interactive cases, followed by a number of questions regarding curability, survival, and possible treatment options. All residents were asked to fill out optional questionnaires before and after this workshop. A total of 64 residents participated in this study with an average of 16 residents per session. Significant deficits in knowledge were identified, and prognosis was estimated correctly by 40% of residents when presented with a variety of clinical scenarios. We demonstrated an increase in comfort level in basic oncology concerns, comfort level at estimating prognosis, and managing toxicity based on pre- and post-level testing. Our results confirm that the oncology inpatient rotation may not be adequate in educating residents. The format of our workshop demonstrates that it is possible to create and implement a focused intervention with fairly limited resources. This can serve as a platform for evaluation of oncology medical education of internal medicine residents at other institutions.
Appendix
Available only for authorised users
Literature
10.
go back to reference Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, Cowey CL, Schadendorf D, Wagstaff J, Dummer R, Ferrucci PF, Smylie M, Hogg D, Hill A, Márquez-Rodas I, Haanen J, Guidoboni M, Maio M, Schöffski P, Carlino MS, Lebbé C, McArthur G, Ascierto PA, Daniels GA, Long GV, Bastholt L, Rizzo JI, Balogh A, Moshyk A, Hodi FS, Wolchok JD (2019) Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 381(16):1535–1546. https://doi.org/10.1056/NEJMoa1910836CrossRefPubMed Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, Cowey CL, Schadendorf D, Wagstaff J, Dummer R, Ferrucci PF, Smylie M, Hogg D, Hill A, Márquez-Rodas I, Haanen J, Guidoboni M, Maio M, Schöffski P, Carlino MS, Lebbé C, McArthur G, Ascierto PA, Daniels GA, Long GV, Bastholt L, Rizzo JI, Balogh A, Moshyk A, Hodi FS, Wolchok JD (2019) Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 381(16):1535–1546. https://​doi.​org/​10.​1056/​NEJMoa1910836CrossRefPubMed
11.
go back to reference FitzGerald JD, Wenger NS (2003) Didactic teaching conferences for IM residents: who attends, and is attendance related to medical certifying examination scores? Acad Med 78(1):84–89CrossRefPubMed FitzGerald JD, Wenger NS (2003) Didactic teaching conferences for IM residents: who attends, and is attendance related to medical certifying examination scores? Acad Med 78(1):84–89CrossRefPubMed
Metadata
Title
A Critical Appraisal and Targeted Intervention of the Oncology Experience in an Internal Medicine Residency
Authors
Ghulam Rehman Mohyuddin
Anthony Dominick
Travis Black
Marc Hoffman
Heather Male
Kenneth Byrd
Brian McClune
Leigh Eck
Prakash Neupane
Publication date
01-12-2021
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 6/2021
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-020-01766-6

Other articles of this Issue 6/2021

Journal of Cancer Education 6/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine